Advertisement

Advertisement

2020 Annual Meeting of the Society for Immunotherapy of Cancer

Skin Cancer

Intratumoral Injections May Boost Neoadjuvant Response in Resectable Melanoma

Studies reported at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting, which was held virtually, showed promise for the use of intratumoral injections of novel immunotherapies in trea...

Skin Cancer

Novel Combination Under Study in First-Line Treatment of Metastatic Melanoma

A first-line regimen combining the novel interleukin-2 (Il-2) agonist bempegaldesleukin (NKTR-214) with nivolumab showed encouraging clinical activity in patients with metastatic melanoma in the phase...

Advertisement

Advertisement



Advertisement